Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1. Current formulations for nasal drug delivery [22]

Published byTiffany Reed Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 1. Current formulations for nasal drug delivery [22]"— Presentation transcript:

1 Table 1. Current formulations for nasal drug delivery [22]
Indication Active pharmaceutical ingredient Formulation Analgesia Diamorphine hydrochloride Fentanyl citrate Powder and diluent for reconstitution-aqueous spray Nasal spray, solution Acute treatment of migraine Sumatriptan Zolmitriptan Nasal spray, solution Endometriosis Ovarian stimulation Nafarelin acetate Nasal congestion (associated with sinusitis, common cold, rhinitis and other UTIs) Symptomatic relief of rhinorrhoea Xylometazoline hydrochloride Oxymetazoline hydrochloride Azelastine Hydrochloride  Ephedrine Ipatropium bromide Nasal spray, solution, nasal drops Nasal drops Prophylaxis and treatment of perennial and seasonal allergic rhinitis  Budesonide, beclometasone dipropionate (and monohydrate (micronized), Mometasone furoate Triamcinolone acetonide Fluticasone propionate Fluticasone furoate Fluticasone with azelastine HCl Sodium cromoglicate Nasal spray suspension Nasal spray suspension, spray solution Prostatic carcinoma (hormone -dependent) Buserelin acetate Nasal congestion Levomenthol Nasal ointment Nasal infection Neomycin sulfate and Chlorhexidine dihydrochoride Nasal cream Nicotine withdrawal symptoms Nicotine Nasal Spray Solution Nocturia associated with multiple sclerosis The diagnosis and treatment of vasopressin-sensitive cranial diabetes insipidus. Establishing renal concentration capacity. Desmopressin acetate Vaccinations Influenza vaccine Muhammad U. Ghori et al. Nasal Drug Delivery Systems: An Overview. American Journal of Pharmacological Sciences, 2015, Vol. 3, No. 5, doi: /ajps-3-5-2 © The Author(s) Published by Science and Education Publishing.

Download ppt "Table 1. Current formulations for nasal drug delivery [22]"

Similar presentations

Difficulties in showing a dose- response with locally-acting nasal sprays and aerosols for allergic rhinitis Badrul A. Chowdhury, MD, PhD Medical Team.

Difficulties in showing a dose- response with locally-acting nasal sprays and aerosols for allergic rhinitis Badrul A. Chowdhury, MD, PhD Medical Team.
Difficulties in showing a dose- response with locally-acting nasal sprays and aerosols for allergic rhinitis Badrul A. Chowdhury, MD, PhD Medical Team.

Difficulties in showing a dose- response with locally-acting nasal sprays and aerosols for allergic rhinitis Badrul A. Chowdhury, MD, PhD Medical Team.
NDAC December 14, 2007 1 Nonprescription Drugs Advisory Committee Meeting Silver Spring, Maryland December 14, 2007 Mary S. Robinson, MS Division of Nonprescription.

NDAC December 14, Nonprescription Drugs Advisory Committee Meeting Silver Spring, Maryland December 14, 2007 Mary S. Robinson, MS Division of Nonprescription.
Antihistamines and Nasal Decongestants

Antihistamines and Nasal Decongestants
Drugs for Allergic Rhinitis, Cough, and Colds. Allergic Rhinitis  Inflammatory disorder of the upper airway, lower airway, and eyes  Symptoms  Sneezing.

Drugs for Allergic Rhinitis, Cough, and Colds. Allergic Rhinitis  Inflammatory disorder of the upper airway, lower airway, and eyes  Symptoms  Sneezing.
and Statistics, 2016, Vol. 4, No. 1, 1-8. doi: /ajams-4-1-1

and Statistics, 2016, Vol. 4, No. 1, 1-8. doi: /ajams-4-1-1
Drugs for Allergic Rhinitis, Cough, and Colds

Drugs for Allergic Rhinitis, Cough, and Colds
© The Author(s) Published by Science and Education Publishing.

© The Author(s) Published by Science and Education Publishing.
Hospital live Deliveries

Hospital live Deliveries
Research, 2015, Vol. 3, No. 6, doi: /education

Research, 2015, Vol. 3, No. 6, doi: /education
Table 1. The French-American-British (FAB) classification of AML

Table 1. The French-American-British (FAB) classification of AML
Table 3. Number of MS patients/ Year of diagnosis / Current Residence

Table 3. Number of MS patients/ Year of diagnosis / Current Residence
Table 2. Number of MS patients/ Year diagnosis /Place of Birth

Table 2. Number of MS patients/ Year diagnosis /Place of Birth
osteoporosis among the studied working women (n= 365)

osteoporosis among the studied working women (n= 365)
intervals from six months to one year

intervals from six months to one year
Buy Fluticasone can you buy flonase nasal spray over the counter buy fluticasone propionate ointment buy fluticasone online buy avamys fluticasone furoate.

Buy Fluticasone can you buy flonase nasal spray over the counter buy fluticasone propionate ointment buy fluticasone online buy avamys fluticasone furoate.
David B Allen, MD  Journal of Allergy and Clinical Immunology 

David B Allen, MD  Journal of Allergy and Clinical Immunology 
Community pharmacy lecture no.5 respiratory system rhinitis

Community pharmacy lecture no.5 respiratory system rhinitis
Clinical outcomes and adverse effect monitoring in allergic rhinitis

Clinical outcomes and adverse effect monitoring in allergic rhinitis
Muro Pharmaceutical, Inc. An ASTA Medica company March 20, 2001

Muro Pharmaceutical, Inc. An ASTA Medica company March 20, 2001

Similar presentations

Ads by Google